Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
for
FSHD
Location: Los Angeles CA, Stanford CA, Salt Lake City UT,
Sponsor: University of Kansas Medical Center
Sex: All
Age: 0+
Code: NCT04635891
Recruiting
Multi-center Trial to Improve Nocturia and Sleep in Older Adults
for
Nocturia, Insomnia
Location: Los Angeles CA, Atlanta GA
Sponsor: Atlanta VA Medical Center
Sex: All
Age: 60+
Code: NCT06110091
Recruiting
Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease
for
Hirschsprung Disease, Enterocolitis
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 0 - 17
Code: NCT02193685
Recruiting
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
for
Gender Dysphoria
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT04979338
Phase 3, Recruiting
Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience
for
Hepatitis C
Location: Colton CA
Sponsor: Arrowhead Regional Medical Center
Sex: All
Age: 18 - 70+
Code: NCT02485262
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
for
Refractory Solid Tumors, Relapsed Solid Tumors,
Location: Los Angeles CA, San Francisco CA, Salt Lake City UT,
Sponsor: Theodore Laetsch
Sex: All
Age: 1 - 30
Code: NCT06721689
Phase 1, Phase 2, Recruiting
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
for
Down Syndrome, Fetal Aneuploidy
Location: Los Angeles CA, San Diego CA, Iowa City IA, Chicago IL,
Sponsor: Sequenom, Inc.
Sex: Female
Age: 18+
Code: NCT01429389
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors